Estimating risk of prolonged mechanical ventilation after liver transplantation in children: PROVE-ALT score

Muhammad Umair M Mian1, Curtis E Kennedy2, Jorge A Coss-Bu2

  • 1Division of Child Health, University of Missouri School of Medicine, Springfield Clinical Campus, Columbia, Missouri, USA.

Pediatric Transplantation
|October 14, 2023
PubMed

Insights

A new score, PROVE-ALT, accurately predicts prolonged mechanical ventilation (PMV) in children after liver transplantation (LT). This tool helps optimize care and resources for high-risk pediatric LT patients.

Area of Science:

  • Pediatric Surgery
  • Critical Care Medicine
  • Transplantation Medicine

Background:

  • Identifying children at high risk for prolonged mechanical ventilation (PMV) post-liver transplantation (LT) is crucial for optimizing pulmonary support and surgical outcomes.
  • Early risk stratification aids in resource allocation and tailored patient management strategies.

Purpose of the Study:

  • To develop and validate a predictive metric, the PROVE-ALT score, for estimating the risk of prolonged mechanical ventilation after pediatric liver transplantation.
  • To identify key preoperative risk factors associated with PMV in pediatric LT recipients.

Main Methods:

  • A retrospective cohort study involving pediatric LT recipients (n=338) was conducted.
  • Preoperative risk factors for PMV were identified using univariable analysis.
  • The PROVE-ALT score was developed using multivariable logistic regression and validated in a separate cohort.

Main Results:

  • The PROVE-ALT score demonstrated high accuracy in predicting PMV in the validation cohort (AUC: 0.81), with 73% sensitivity and 80% specificity.
  • Independent risk factors for PMV included cirrhosis, age <1 year, need for preoperative continuous renal replacement therapy (CRRT), and pre-LT management in hospital (MIH).
  • The PROVE-ALT score cutoff of ≥8 accurately predicted PMV.

Conclusions:

  • The PROVE-ALT score is a sensitive and specific tool for predicting PMV in pediatric LT patients.
  • External validation is recommended to facilitate its widespread clinical adoption.
  • The PROVE-ALT score can guide patient-specific ventilation strategies, parental counseling, and resource optimization.
Abstract